Lumbar Belt Benefit Compared to the Usual Care in the Treatment of Non-specific Low Back Pain

Thuasne168 enrolled

Overview

Lumbar belt benefit compared to the usual care in the treatment of non-specific low back pain -an interventional, prospective, multicenter, randomized, open and controlled.study

This is a controlled study, with randomization of the patients, which aims at evaluating the benefit and interest of wearing a new generation lumbar belt, in patients suffering from non-specific low back pain. This trial is also designed to provide quality of life data and to assess the medico-economic interest of wearing such a lumbar belt. This is an interventional study with low risks and constraints that does not deviate from the local standard of care for enrolled patients. No invasive examination or procedure is performed; as such, there will be no additional risks for participating patients. 203 patients will be followed during 12 weeks in up to 20 investigational sites Patients meeting all eligibility criteria will be included in the study and randomized into one of the two following groups on a 1: 1 ratio. * Control group "usual care": promotion of physical activity and taking usual medicines for pain relief * Intervention group: wearing the LombaStab belt in addition to usual care (promotion of physical activity and taking usual medicines for pain relief). Three visits will be performed: * Inclusion visit - baseline D0 - V0 * Follow-up visit at week 4 (+/- 5 days) - V1 * Follow-up visit at week 12 (+/- 5 days) - V2 At inclusion visit, after verification of the eligibility criteria, data regarding patients will be collected: demographic data, low back pain history, medical and surgical history, concomitant medications. At each visit will be performed: * physical examinations and score assessment by the investigator: ODI score, finger-to-floor distance test, Schober Mac Rae test * medical interview with patient in order to collect the following information: description of pain, drug consumption, duration of sick leave and resumption of activity at work, use of medical resources (consultations and complementary). * reporting of all AEs and device deficiencies Patients will be asked to complete on-line questionnaires, following visits and each week.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

168

Conditions

Low Back Pain

Interventions

LombaStab beltDEVICE

Instruction given to the patient will be to wear the LombaStab belt from 4 to 8 hours per days, over the whole duration of the study (12 weeks). The investigator will explain to the patient how to adjust it. The LombaStab belt will be equiped with thermosensor to evaluate the belt wearing time at the end of the study.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female, aged from 18 to 55 years old * Patient suffering from non-specific low back pain with current episode has progressed for 1 to 6 months * At least one lumbar mean pain at rest or at effort of the last 72 hours collected on inclusion ≥ 40/100 on an NRS scale. * Ability of the patient or legally authorized representative to provide a signed and dated i informed consent form before any procedure or data collection. * Patient covered by the French Social security system. Exclusion Criteria: * Patient wearing a lumbar belt the day of the inclusion visit * Patient who has had surgical intervention on dorso-lumbar spine or lower limb the past 5 years or who has planned surgery during the study * MODIC diagnosis (disc degeneration) known or confirmed by MRI * On sick leave for more than 3 consecutive months due to low back pain at the time of inclusion * Low back pain related to an accident at work * Low back pain due to secondary origin: tumor, inflammatory, infectious cause, related to a fracture or a vertebral compression * Patient with fibromyalgia * Patient with lumbar radicular syndrome (radicular conflict like disc herniation, spinal stenosis...) * Pregnant woman or trying to become pregnant during the study * Patient with confirmed depression * Patient with cognitive or mental disorders * Morphology with measurements not allowing to match with the sizes of belts available * Patient presenting chronic pathology with disabling functional consequences * Patient who received an infiltration less than one month before inclusion visit or planned during the study * Patient with known allergy to any of the materials (see product composition in the Description section of user instruction) * Patient with contraindicated to belt wearing: hiatus hernia, deficient respiratory functions * Anticipated poor compliance of subject with study procedures * Current participation in an interventional investigation drug or device treatment study with an impact on evaluation criteria

Locations (3)

CHU Grenoble Alpes

Grenoble, France

Hôpital Cochin

Paris, France

CHU de St Etienne

Saint-Etienne, France

Outcomes

Primary Outcomes

Change from baseline ODI score (Oswestry Disability Index) at 12 weeks

The functional capacity is measured by ODI score.The ODI questionnaire consists in 10 questions and 6 answers modalities.The ODI score results are expressed in percentage.The higher the percentage is, the more the functional capacity is impaired.

Time frame: Week: 0 and 12

Secondary Outcomes

Evolution of functional capacity

Time frame: Week: 0 and 4

Evolution of pain level

Pain level is measured by NRS scale completed by the patient : minimum, maximum, mean at effort and at rest : 0 corresponds to no pain (better outcome) and 10 to maximum pain (worst outcome)

Time frame: Week: 0, 4 and 12

Evolution of pain characteristics

Characteristics of pain are evaluated by specific questions regarding the description of pain

Time frame: Week: 0, 4 and 12

Evolution of Quality of Life

Quality of life is measured by the EQ5D questionnaire completed by the patient. The EQ-5D questionnaire has two components: health state description and evaluation. In the description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Mobility dimension asks about the person's walking ability. Self-care dimension asks about the ability to wash or dress by oneself, and usual activities dimension measures performance in "work, study, housework, family or leisure activities". In pain/discomfort dimension, it asks how much pain or discomfort they have, and in anxiety/depression dimension, it asks how anxious or depressed they are. The respondents self-rate their level of severity for each dimension using five-level (EQ-5D-5L) scale. In the evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.